Hansa Biopharma AB (publ)

Stockholm Stock Exchange:HNSA.ST

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

Sweden

Market Cap

USD 239.85 M

Share Price

USD 2.90

Avg Daily Volume

333,573

Change (1 day)

-8.24%

Change (1 year)

-21.25%

Change (YTD)

-18.09%

Hansa Biopharma AB (publ) Accounts Payable for the year ending December 31, 2022: USD 5.97 M

Hansa Biopharma AB (publ) Accounts Payable is USD 5.97 M for the year ending December 31, 2022, a 1.56% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Hansa Biopharma AB (publ) Accounts Payable for the year ending December 31, 2021 was USD 5.87 M, a 81.76% change year over year.
Hansa Biopharma AB (publ) Accounts Payable for the year ending December 31, 2020 was USD 3.23 M, a -39.93% change year over year.
Hansa Biopharma AB (publ) Accounts Payable for the year ending December 31, 2019 was USD 5.38 M, a 18.32% change year over year.
Hansa Biopharma AB (publ) Accounts Payable for the year ending December 31, 2018 was USD 4.55 M.